12 completed, 2 terminated, 1 recruiting. 15 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 15 | Completed 12, Terminated 2, Recruiting 1 |
Follow Boostrix: new trials by email Literature Review of Boostrix trials Research Report on Boostrix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy Tdap Vaccine Administration, RSV Vaccine, Saline (as a placebo) - RSV, Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination | Phase 4 | Recruiting | Canadian Immunization Research Network | 60 | 2025-10-16 | 2026-10-22 |
| The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd) Hepatitis A vaccine, Diphtheria, pertussis, and tetanus booster vaccine - Rheumatic Diseases | Phase 4 | Terminated | Oregon Health and Science University | 129 | 2022-10-11 | 2026-09-24 |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women Boostrix™, Saline placebo - Diphtheria-Tetanus-acellular Pertussis Vaccines | Phase 4 | Completed | GlaxoSmithKline | 688 | 2015-10-14 | 2020-01-28 |
| Placebo Controlled Study to Generate Data Characterising Safety Parameters and Immune Responses Boostrix, Placebo (Saline) - Prevention of Infections With Bordetella Pertussis | Phase 4 | Completed | University Hospital, Ghent | 240 | 2015-08-24 | 2022-12-20 |
| Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand Boostrix, Infanrix hexa, Quinvaxem - Pertussis | Phase 4 | Completed | Universiteit Antwerpen | 370 | 2015-04-01 | 2019-10-24 |
| A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' Assays Menveo®, Boostrix®, Pneumovax 23® - Meningococcal | Phase 4 | Completed | GlaxoSmithKline | 359 | 2014-04-01 | 2017-11-27 |
| Pertussis and Meningitis C Concomitant Vaccination in Adolescents Meningococcal vaccine, Pertussis containing vaccine - Pertussis, Meningitis | Phase 4 | Completed | Public Health England | 400 | 2013-09-01 | 2019-03-22 |
| Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®), Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (BOOSTRIX®) - Tetanus, Diphtheria | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 423 | 2012-06-01 | 2016-03-02 |
| Pertussis (Tdap) Vaccination in Pregnancy Pertussis vaccine - Pertussis, Pregnancy | Phase 4 | Completed | Universiteit Antwerpen | 99 | 2012-02-01 | 2019-10-24 |
| Evaluation of Boostrix™10 Years After Previous Booster Vaccination Boostrix™, Boostrix™-US formulation - Acellular Pertussis, Tetanus | Phase 4 | Completed | GlaxoSmithKline | 180 | 2010-06-15 | 2018-08-20 |
| Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058 Boostrix™ - Acellular Pertussis, Tetanus | Phase 4 | Completed | GlaxoSmithKline | 203 | 2007-11-05 | 2020-01-13 |
| Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX® ADACEL®:Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed, BOOSTRIX®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed - Pertussis, Tetanus | Phase 4 | Completed | Sanofi | 647 | 2006-05-01 | 2012-10-05 |
| US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease Boostrix®, Menactra™ - Acellular Pertussis, Tetanus | Phase 4 | Completed | GlaxoSmithKline | 1344 | 2006-01-25 | 2018-08-17 |
| Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines. INFANRIX, BOOSTRIX, HAVRIX - Acellular Pertussis, Tetanus | Phase 4 | Terminated | GlaxoSmithKline | 720 | 2003-05-01 | 2016-09-07 |
| Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV) Boostrix™ (dTpa), GSK Biologicals' reduced-antigen-content combined diphtheria, tetanus, acellular pertussis and inactivated polio vaccine (dTpa-IPV; BoostrixTM), Ditanrix™ Adult, TedivaxTM (Td) - Acellular Pertussis, Tetanus | Phase 4 | Completed | GlaxoSmithKline | 460 | 2003-04-01 | 2016-09-15 |
Diphtheria (9) · Tetanus (8) · Whooping Cough (7) · Meningitis (1) · Rheumatic Diseases (1)
GlaxoSmithKline (7) · Universiteit Antwerpen (2) · Canadian Immunization Research Network (1) · Oregon Health and Science University (1) · Public Health England (1) · Sanofi (1) · Sanofi Pasteur, a Sanofi Company (1) · University Hospital, Ghent (1)
Belgium (4) · United States (4) · Australia (3) · Canada (3) · Spain (2) · Czechia (1) · Finland (1) · Italy (1) · Netherlands (1) · Thailand (1) · United Kingdom (1) · Vietnam (1)
Bahaa Abu-Raya, M.D., PhD (1) · Elke Leuridan, MD PhD (1) · Elke Leuridan, MD, PhD (1) · Geert Leroux-Roels, Prof., MD (1) · Thu Ha Thi Hoang, MD PhD (1)
PMID 21134450, PMID 25613716, PMID 27142328, PMID 31301919, PMID 31418814, PMID 32331806, PMID 35135700, PMID 37285482, PMID 38752802, PMID 39066382, PMID 39385752, PMID 41122946
2014 (1)